Redefining the Diagnosis of Type 1 Diabetes

Updated criteria could open new possibilities for intervention before symptoms appear JDRF is leading a pertinent discussion in the diabetes field about what defines a diagnosis of type 1 diabetes (T1D). At the 14th Annual Rachmiel Levine Diabetes and Obesity Symposium today, Richard Insel, M.D., JDRF’s chief scientific officer, reviewed evidence supporting the need to […]

Discovery of New Hormone May Impact T1D

The media has come alive, exciting the type 1 diabetes (T1D) community, following the publication of findings of a new hormone in Cell on April 25. The previously unknown hormone, called betatrophin, was found in a mouse study to have the unique ability to promote the natural replication of insulin-producing beta cells. While media reports […]